---
figid: PMC7572679__nihms-1628120-f0002
figtitle: Metformin modulates lipid metabolism in the intestine, liver, and adipose
  tissue
organisms:
- NA
pmcid: PMC7572679
filename: nihms-1628120-f0002.jpg
figlink: /pmc/articles/PMC7572679/figure/F2/
number: F2
caption: (Left) In the intestine, metformin stimulates GLP-1 expression and secretion
  through AMPK-dependent and -independent pathway in L cells. Metformin inhibits chylomicron
  assembly and secretion in enterocytes by reducing the levels of Apo-48, Apo-IV,
  and triglyceride synthesis. (Middle) In the liver, metformin-mediated activation
  of AMPK phosphorylates SREBP-1 and ACC to inhibit the de novo lipogenesis (DNL),
  disinhibits the activity of CPT-1; metformin also promotes the mitochondrial fission
  to increase mitochondria number; these metformin’s effects lead to elevated fatty
  acid oxidation. (Right) In brown adipocytes, metformin stimulates fatty acid uptake
  and activates HSL to increase lipolysis. Metformin increases mitochondrial biogenesis
  by activating PGC-1 signaling. Activated AMPK also drives mitochondrial fission.
  Collectively, metformin augments fatty acid oxidation in brown adipose tissue. The
  black arrows indicate the direct effects, and the shaded arrows indicate the indirect
  effects. ACC1/2, acetyl-coenzyme A carboxylase 1/2; CAMKII, calcium/calmodulin-activated
  protein kinase II; CPT1, carnitine palmitoyltransferase 1; DAG, diacylglycerols;
  DGAT, diacylglycerol acyltransferase; FAS, fatty acid synthase; HSL, hormone-sensitive
  lipase; MAG, monoacylglycerols; MGAT, monoacylglycerol acyltransferase; PGC-1α,
  peroxisome proliferator-activated receptor gamma coactivator 1α; PKA, protein kinase
  A; SREBP1, sterol regulatory element binding protein 1; TG. triglycerides.
papertitle: Metformin and Systemic Metabolism.
reftext: Ling He. Trends Pharmacol Sci. ;41(11):868-881.
year: '2020'
doi: 10.1016/j.tips.2020.09.001
journal_title: Trends in pharmacological sciences
journal_nlm_ta: Trends Pharmacol Sci
publisher_name: ''
keywords: Metformin | insulin resistance | nutrient metabolism | mitochondria
automl_pathway: 0.9315721
figid_alias: PMC7572679__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC7572679__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7572679__nihms-1628120-f0002.html
  '@type': Dataset
  description: (Left) In the intestine, metformin stimulates GLP-1 expression and
    secretion through AMPK-dependent and -independent pathway in L cells. Metformin
    inhibits chylomicron assembly and secretion in enterocytes by reducing the levels
    of Apo-48, Apo-IV, and triglyceride synthesis. (Middle) In the liver, metformin-mediated
    activation of AMPK phosphorylates SREBP-1 and ACC to inhibit the de novo lipogenesis
    (DNL), disinhibits the activity of CPT-1; metformin also promotes the mitochondrial
    fission to increase mitochondria number; these metformin’s effects lead to elevated
    fatty acid oxidation. (Right) In brown adipocytes, metformin stimulates fatty
    acid uptake and activates HSL to increase lipolysis. Metformin increases mitochondrial
    biogenesis by activating PGC-1 signaling. Activated AMPK also drives mitochondrial
    fission. Collectively, metformin augments fatty acid oxidation in brown adipose
    tissue. The black arrows indicate the direct effects, and the shaded arrows indicate
    the indirect effects. ACC1/2, acetyl-coenzyme A carboxylase 1/2; CAMKII, calcium/calmodulin-activated
    protein kinase II; CPT1, carnitine palmitoyltransferase 1; DAG, diacylglycerols;
    DGAT, diacylglycerol acyltransferase; FAS, fatty acid synthase; HSL, hormone-sensitive
    lipase; MAG, monoacylglycerols; MGAT, monoacylglycerol acyltransferase; PGC-1α,
    peroxisome proliferator-activated receptor gamma coactivator 1α; PKA, protein
    kinase A; SREBP1, sterol regulatory element binding protein 1; TG. triglycerides.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC5A1
  - CAMK2G
  - GSK3B
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CTNNB1
  - TCF7
  - GCG
  - GLP1R
  - EHMT1
  - ZGLP1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MAG
  - MGAT1
  - MGAT2
  - MGAT3
  - MGAT4A
  - MGAT4B
  - MGAT4C
  - MGAT4D
  - MGAT5
  - MGAT5B
  - DGAT1
  - APOB
  - TG
  - SREBF1
  - ACACA
  - BMS1
  - ACACB
  - FAS
  - FASN
  - MFF
  - CPT1A
  - CPT2
  - CHPT1
  - DNASE2
  - LIPE
  - PPARGC1A
  - CaMKII
  - sgg
  - Axn
  - gskt
  - arm
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - GlyP
  - SNF4Agamma
  - AMPKalpha
  - mag
  - Mgat1
  - Mgat4a
  - Mgat4b
  - Mgat2
  - Mgat3
  - Dgat2
  - Gat
  - mdy
  - Tg
  - SREBP
  - ACC
  - tacc
  - acclinal-wing
  - Fas2
  - FASN1
  - Fas3
  - fand
  - tei
  - rg
  - FASN2
  - FASN3
  - ww
  - whd
  - Drl-2
  - Hsl
  - srl
  - pgc
---
